Success Metrics

Clinical Success Rate
100.0%

Based on 17 completed trials

Completion Rate
100%(17/17)
Active Trials
8(21%)
Results Posted
12%(2 trials)

Phase Distribution

Ph phase_3
2
5%
Ph phase_2
1
3%
Ph phase_4
3
8%
Ph early_phase_1
2
5%
Ph phase_1
1
3%
Ph not_applicable
18
47%

Phase Distribution

3

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
2(7.4%)
Phase 1Safety & dosage
1(3.7%)
Phase 2Efficacy & side effects
1(3.7%)
Phase 3Large-scale testing
2(7.4%)
Phase 4Post-market surveillance
3(11.1%)
N/ANon-phased studies
18(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.0%

17 of 20 finished

Non-Completion Rate

15.0%

3 ended early

Currently Active

8

trials recruiting

Total Trials

38

all time

Status Distribution
Active(11)
Completed(17)
Terminated(3)
Other(7)

Detailed Status

Completed17
Recruiting7
unknown6
Withdrawn3
Not yet recruiting2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
38
Active
8
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.4%)
Phase 11 (3.7%)
Phase 21 (3.7%)
Phase 32 (7.4%)
Phase 43 (11.1%)
N/A18 (66.7%)

Trials by Status

withdrawn38%
enrolling_by_invitation13%
not_yet_recruiting25%
active_not_recruiting13%
recruiting718%
completed1745%
unknown616%
suspended13%

Recent Activity

8 active trials
Showing 5 of 38
not_yet_recruitingnot_applicable

Optimizing Stimulation Parameters for Electroconvulsive Therapy

NCT07561307
active_not_recruitingphase_2

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

NCT05054699
not_yet_recruitingnot_applicable

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

NCT07533773
completednot_applicable

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

NCT07526454
recruitingnot_applicable

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

NCT07473648
View all 38 trials

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT07561307Not Applicable

Optimizing Stimulation Parameters for Electroconvulsive Therapy

Not Yet Recruiting
NCT05054699Phase 2

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

Active Not Recruiting
NCT07533773Not Applicable

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

Not Yet Recruiting
NCT07526454Not Applicable

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Completed
NCT07473648Not Applicable

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

Recruiting
NCT06733558Early Phase 1

Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT

Withdrawn
NCT07324070Not Applicable

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

Recruiting
NCT05630469

Prediction of Antidepressant Effects of Electroconvulsive Therapy

Recruiting
NCT06355180Not Applicable

Esketamine vs ECT for Acute Suicidality

Completed
NCT03191058Not Applicable

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression

Completed
NCT05973643Not Applicable

Metabolomics During ElectroConvulsivoTherapy

Recruiting
NCT04057378Phase 4

Optimal Electrical Stimulus During Electroconvulsive Therapy

Recruiting
NCT04059952

Mechanism of Action of Electroconvulsive Therapy

Completed
NCT06682299Not Applicable

Maintenance TMS in Treatment Resistant Depression

Recruiting
NCT04160286

The Danish Neuropsychological Study of the Adverse Effects of ECT

Completed
NCT05515159

Blood Biomarkers in Electroconvulsive Therapy

Enrolling By Invitation
NCT04348825

Electroconvulsive Therapy and Neuroradiology

Completed
NCT05388461

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

Recruiting
NCT03674671Phase 3

Ketamine Versus Electroconvulsive Therapy in Depression

Suspended
NCT02871141

Multimodal Imaging of ECT Effects

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
38